Patents by Inventor Eckhard Milsmann

Eckhard Milsmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Safety containers for biologically active substances and method for producing said container
    Publication number: 20070010700
    Abstract: The invention relates to safety containers for biologically active substances, in particular cytostatic agents, said container having increased or higher fracture strength and shatterproof qualities, in addition to an uncontaminated exterior. The invention also relates to a method for producing said containers and to the use of a medium containing at least one polymer for decontaminating the exterior of a container that is filled with a biologically active substance, sealed and optionally labelled.
    Type: Application
    Filed: January 9, 2004
    Publication date: January 11, 2007
    Applicant: Baxter International Inc
    Inventors: Hubert Bensmann, Heiko Kranzmann, Eckhard Milsmann, Burkhard Wichert
  • Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis
    Patent number: 6544551
    Abstract: The present invention relates to new solid pharmaceutical compositions containing hexadecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis, a process for the manufacture of said pharmaceutical composition, a dosage scheme for oral administration of said pharmaceutical composition in the treatment of leishmaniasis, and finally a combination comprising said solid pharmaceutical composition, antiemeticum, and/or an antidiarrhoeal.
    Type: Grant
    Filed: July 24, 2000
    Date of Patent: April 8, 2003
    Assignee: Zentaris AG
    Inventors: Juergen Engel, Werner Sarlikiotis, Thomas Klenner, Peter Hilgard, Dieter Sauerbier, Eckhard Milsmann
  • Tablet containing mesna as active substance and method of making same
    Patent number: 5358718
    Abstract: A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain:0.01-1 parts by weight of a binding agent0.03-0.4 parts by weight of a disintegrant0.01-0.2 parts by weight of a lubricant and0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
    Type: Grant
    Filed: July 26, 1993
    Date of Patent: October 25, 1994
    Assignee: Degussa
    Inventors: Dieter Sauerbier, Jurgen Engel, Eckhard Milsmann
  • Tablets and granulates containing mesna as active substance
    Patent number: 5262169
    Abstract: A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain:0.01-1 parts by weight of a binding agent0.03-0.4 parts by weight of a disintegrant0.01-0.2 parts by weight of a lubricant and0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
    Type: Grant
    Filed: July 16, 1991
    Date of Patent: November 16, 1993
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Dieter Sauerbier, Jurgen Engel, Eckhard Milsmann
  • Tablets and granulates containing mesna as active substance
    Patent number: 5252341
    Abstract: A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain0.01-1 parts by weight of a binding agent0.03-0.4 parts by weight of a disintegrant0.01-0.2 parts by weight of a lubricant and0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
    Type: Grant
    Filed: August 17, 1992
    Date of Patent: October 12, 1993
    Assignee: Degussa Aktiengesellschaft
    Inventors: Dieter Sauerbier, Jurgen Engel, Eckhard Milsmann
  • Solid oral dosage forms of ifosfamide
    Patent number: 5158776
    Abstract: Solid oral ifosfamide formulations comprising a capsule containing a mass which consists essentially of the active substance ifosfamide and microcrystalline cellulose, or in the form of tablets which contain, in relation to one part by weight of ifosfamide,0.1-1.0 parts by weight of tribasic calcium phosphate and0.04-0.4 parts by weight of polyethylene glycol as well as in addition, related to the weight of the tablet5-60% by weight of a filling and flow regulating agent1-10% by weight of a disintegrant0.1-10% by weight of an antiadhesion agent and0.1-80% by weight of a binding agent.
    Type: Grant
    Filed: July 24, 1991
    Date of Patent: October 27, 1992
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Dieter Sauerbier, Jurgen Engel, Eckhard Milsmann, Klaus Molge, Otto Isaac